An observational study in Giant Cell Arteritis, sponsored by University Hospital, Brest. Completed at 1 site in France. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2021-08-24.
Sponsored by University Hospital, Brest · Observational
Evaluation of the structural features of temporal arteritis using two frequencies probes: 18 and 22Mhz.
Comparison of the results obtained by using 2 different frequencies probes in the diagnosis of giant cell arteritis
135 studies on the registry are indexed under Polymyalgia Rheumatica; 28 are open to participants now.
This study's enrollment of 80 is below the median of 114 across 65 observational studies indexed under Polymyalgia Rheumatica.
Browse Polymyalgia Rheumatica studies →University Hospital, Brest is the lead sponsor of 594 studies on the registry; 135 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients with suspicion of giant cell arteritis
Exclusion Criteria:
halo sign of temporal arteritis
hypoechogenicity of the wall artery
Time frame: inclusion
compression sign of of temporal arteritis
persistent of increased inflammatory arteries wall
Time frame: inclusion
halo sign of carotid arteritis
hypoechogenicity of the wall artery
Time frame: inclusion
halo sign of subclavian arteritis
hypoechogenicity of the wall artery
Time frame: inclusion
halo sign of axillary arteritis
hypoechogenicity of the wall artery
Time frame: inclusion
other structural abnormalities in unilateral B mode
stenosis, occlusion
Time frame: inclusion
other structural abnormalities in bilateral B mode
stenosis, occlusion
Time frame: inclusion
Plan to share: Yes — All collected data that underlie results in a publication
Supporting information: Study protocol
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Brest